Pre-earnings options volume in Lexicon (LXRX) Pharmaceuticals is normal with calls leading puts 16:1. Implied volatility suggests the market is anticipating a move near 25.9%, or 17c, after results are released. Median move over the past eight quarters is 7.5%.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXRX:
- Largest borrow rate increases among liquid names
- LXRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Biotech Alert: Searches spiking for these stocks today
- Lexicon Pharmaceuticals: Strategic Partnerships and Pipeline Advancements Drive Buy Rating
- Lexicon announces exclusive license agreement with Novo Nordisk for LX9851